Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07738315) titled 'Elemene Liposomes in Endometrial Cancer' on July 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Women's Hospital School Of Medicine Zhejiang University
Condition:
Endometrial Carcinoma
Intervention:
Drug: Elemene Injection/Elemene Oral Emulsion
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: August 1, 2026
Target Sample Size: 212
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07738315
Disclaimer: Cur...